MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice ...

CLARENCE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (OTCBB: XXII), a company focused on smoking cessation and tobacco harm reduction products, today announced X-22, a prescription smoking ...

Biotech company 22nd Century Group (NASDAQ:XXII) must be smiling today after a recent U.S. Food and Drug Administration (FDA) designation has investors celebrating. Indeed, news broke today that the ...

On Monday, the company announced an agreement to fund all intellectual property, licensing and sponsored research payments to North Carolina State University through 2025 in equity as part of a deal ...

WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (OTCBB: XXII.ob) announced today that it completed a merger with 22nd Century Limited, LLC, a company focused on the development of a ...

The average one-year price target for 22nd Century Group (NasdaqCM:XXII) has been revised to $137.70 / share. This is an increase of 1,400.00% from the prior estimate of $9.18 dated January 11, 2026.

22nd Century Group is a mispriced agricultural biotechnology company that is poised to transform the global tobacco and hemp/cannabis markets. Shares are down 60% during the past month, as investors ...

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has launched a new ...

WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (OTCBB: XXII.ob) announced today that it completed a merger with 22nd Century Limited, LLC, a company focused on the development of a ...